Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-08-14 Sale(A) | 2024-08-20 8:46 pm | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 24,999 | $8 | $199,992 | 131,248 (Indirect) | View |
2024-08-14 Purchase | 2024-08-14 8:54 pm | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 500,000 | $8 | $4,000,000 | 216,083 (Indirect) | View |
2024-08-14 Sale | 2024-08-14 8:54 pm | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 24,999 | $9 | $224,991 | 216,083 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-04 Disposition | 2024-10-11 6:12 pm | 2023-12-13 2025-06-13 | IN8BIO INC. | INAB | Fletcher Aaron G.L. BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP BIOS Incysus Co-Invest I LP Bios Clinical Opportunity Fund LP Bios Equity COF LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner | 574,241 | $0 | 11,862,579 (Indirect) | View |
2024-10-04 Option Award | 2024-10-11 6:12 pm | 2023-12-13 2025-10-04 | IN8BIO INC. | INAB | Fletcher Aaron G.L. BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP BIOS Incysus Co-Invest I LP Bios Clinical Opportunity Fund LP Bios Equity COF LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner | 574,241 | $0 | 11,862,579 (Indirect) | View |
2024-08-14 Exercise | 2024-08-14 8:54 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 37,951 | $5.27 | 216,083 (Indirect) | View |
2024-08-14 Conversion | 2024-08-14 8:54 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 9,380,699 | $0 | 216,083 (Indirect) | View |
2024-08-14 Exercise | 2024-08-14 8:54 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 37,951 | $0 | 216,083 (Indirect) | View |
2024-08-12 Option Award | 2024-08-14 8:54 pm | N/A 2034-08-12 | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 15,000 | $0 | 216,083 (Indirect) | View |
Ownership | 2024-08-12 6:30 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Bios Clinical Opportunity Fund LP Bios Equity COF LP BP Directors LP 10% Owner | 0 | $0 | 8,835,435 (Indirect) | View |
Ownership | 2023-12-15 06:02 am | 2023-12-13 N/A | IN8BIO INC. | INAB | Bios Clinical Opportunity Fund LP Bios Equity COF LP 10% Owner | 0 | $0 | 1,722,723 (Direct) | View |
Ownership | 2023-11-13 5:17 pm | N/A N/A | COGNITION THERAPEUTICS INC | CGTX | Bios Clinical Opportunity Fund LP Bios Equity COF LP Director 10% Owner | 0 | $0 | 500,095 (Direct) | View |